Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1981;3:192-197

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alderman, M. H.
Right arrow Articles by Madhavan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alderman, M. H.
Right arrow Articles by Madhavan, S.

Hypertension, Vol 3, 192-197, Copyright © 1981 by American Heart Association


ARTICLES

Management of the hypertensive patient: a continuing dilemma

MH Alderman and S Madhavan

The proper management of mild and moderate hypertension remains a matter of considerable professional disagreement. Major clinical and population research has largely been designed to define a level of blood pressure (BP) at which treatment should be initiated. This paper reviews studies of the natural history of hypertension and the findings of intervention trials to determine whether the BP level alone is adequate to identify, diagnose, and predict the future course of hypertensive patients. Observational data suggest that patients defined by mild elevation of BP are a heterogeneous group who do not share a common prognosis. Moreover, intervention trials reveal that not all those at risk of cardiovascular disease will benefit from hypotensive therapy. Thus, BP level alone defines neither the group at risk nor those likely to benefit from BP reduction. It is therefore concluded that the management of each patient with hypertension should be determined on the basis of available clinical, biochemical, and behavioral as well as epidemiological data.


This article has been cited by other articles:


Home page
JAMAHome page
C. D. Mulrow, J. A. Cornell, C. R. Herrera, A. Kadri, L. Farnett, and C. Aguilar
Hypertension in the Elderly: Implications and Generalizability of Randomized Trials
JAMA, December 28, 1994; 272(24): 1932 - 1938.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
N. M. Kaplan
Response to Dr Moser's Commentary
Arch Intern Med, April 1, 1984; 144(4): 792 - 793.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
N. M. KAPLAN
Hypertension: Prevalence, Risks, and Effect of Therapy
Ann Intern Med, May 1, 1983; 98(5_Part_2): 705 - 709.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
D. A. McCARRON, J. STANTON, H. HENRY, and C. MORRIS
Assessment of Nutritional Correlates of Blood Pressure
Ann Intern Med, May 1, 1983; 98(5_Part_2): 715 - 719.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
N. M. Kaplan
Mild Hypertension: When and How to Treat
Arch Intern Med, February 1, 1983; 143(2): 255 - 259.
[Abstract] [PDF]


Home page
JAMAHome page
N. M. Kaplan
Therapy for Mild Hypertension: Toward a More Balanced View
JAMA, January 21, 1983; 249(3): 365 - 367.
[Abstract] [PDF]